![Charles Bramlage](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Bramlage
Chief Executive Officer at
Yamo Pharmaceuticals LLC
Profile
Mr. Charles J.
Bramlage is a Chief Executive Officer at Yamo Pharmaceuticals LLC.
He is on the Board of Directors at Clarametyx Biosciences, Inc. Mr. Bramlage was previously employed as an Independent Director by Eiger BioPharmaceuticals, Inc., an Independent Director by BioDelivery Sciences International, Inc., a President, Chief Executive Officer & Director by Pearl Therapeutics, Inc., a President-Pharmaceutical Products by Covidien Ltd., a President-North America & EMEA by Valeant Pharmaceuticals International Corp., a President & Chief Executive Officer by BattellePharma Inc., a VP-Respiratory Global Commercial Development by GlaxoSmithKline Plc, and a Principal by Merck & Co., Inc. He also served on the board at Locus Biosciences, Inc. He received his undergraduate degree from Fisher College of Business and an MBA from the University of Dayton.
Charles Bramlage active positions
| Companies | Position | Start |
|---|---|---|
Clarametyx Biosciences, Inc.
 Clarametyx Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops immune enabling biological therapies to counter persistent infections associated with biofilms | Director/Board Member | - |
Yamo Pharmaceuticals LLC
 Yamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Chief Executive Officer | - |
Former positions of Charles Bramlage
| Companies | Position | End |
|---|---|---|
| EIGER BIOPHARMACEUTICALS | Director/Board Member | 2018-01-03 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Director/Board Member | 2017-12-06 |
Pearl Therapeutics, Inc.
 Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases | Chief Executive Officer | 2016-10-31 |
Covidien Unlimited Co.
 Covidien Unlimited Co. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices and pharmaceuticals | Corporate Officer/Principal | 2010-12-31 |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Corporate Officer/Principal | 2008-06-30 |
Training of Charles Bramlage
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Ventaira Pharmaceuticals, Inc.
 Ventaira Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops aerosol devices | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Dayton
 University of Dayton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Covidien Unlimited Co.
Covidien Unlimited Co. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices and pharmaceuticals | Health Technology |
Pearl Therapeutics, Inc.
Pearl Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for the treatment of chronic respiratory diseases | Health Technology |
Fisher College of Business
 Fisher College of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Locus Biosciences, Inc.
 Locus Biosciences, Inc. Packaged SoftwareTechnology Services Develops AI-enabled precision medicine for infectious diseases and immunology | Technology Services |
Eiger BioPharmaceuticals, Inc.
 Eiger BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat and cure hepatitis delta virus and other serious diseases | Health Technology |
Yamo Pharmaceuticals LLC
Yamo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Clarametyx Biosciences, Inc.
Clarametyx Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops immune enabling biological therapies to counter persistent infections associated with biofilms | Health Technology |
- Stock Market
- Insiders
- Charles Bramlage
